AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford's potential new vaccine
This announcement contains inside information 21 May 2020 07:00 BST AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford's potential new vaccine Company working on a number of agreements in parallel to ensure broad and equitable supply of the vaccine throughout the world at no profit during the pandemic First agreements to supply at least 400 million doses; Company has total capacity sourced for one billion doses through 2020 and into 2021; continues to increase capacity further More than $1bn US BARDA investment to